Show simple item record

dc.contributor.authorRingeisen, F.
dc.contributor.authorRoyce, M.
dc.contributor.authorManlius, C.
dc.contributor.authorLin, J. C. J.
dc.contributor.authorRidolfi, A.
dc.contributor.authorVillanueva, C.
dc.contributor.authorTsugawa, K.
dc.contributor.authorToyama, T.
dc.contributor.authorNoh, W.
dc.contributor.authorJeong, J.
dc.contributor.authorCardoso, F.
dc.contributor.authorSriuranpong, V.
dc.contributor.authorSrimuninnimit, V.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorKendall, S.
dc.contributor.authorFalkson, C.
dc.contributor.authorCianfrocca, M.
dc.date.accessioned2021-03-02T21:23:21Z
dc.date.available2021-03-02T21:23:21Z
dc.identifier.citationVillanueva C., Tsugawa K., Toyama T., Noh W., Jeong J., Cardoso F., Sriuranpong V., Srimuninnimit V., Ozguroglu M., Kendall S., et al., "Stomatitis in patients treated with first-line everolimus (EVE) plus letrozole (LET): Results from BOLERO-4 trial", San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 6 - 10 Aralık 2016, cilt.77
dc.identifier.othervv_1032021
dc.identifier.otherav_06b4bbd3-6808-4e31-937c-7401cae58b53
dc.identifier.urihttp://hdl.handle.net/20.500.12627/10348
dc.identifier.urihttps://doi.org/10.1158/1538-7445.sabcs16-p2-11-08
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleStomatitis in patients treated with first-line everolimus (EVE) plus letrozole (LET): Results from BOLERO-4 trial
dc.typeBildiri
dc.contributor.departmentCHU Besancon , ,
dc.identifier.volume77
dc.contributor.firstauthorID151213


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record